Omentin, an adipokine with insulin-sensitizing properties, is negatively associated with insulin resistance in normal gestation

Journal of Perinatal Medicine

Volumn 43, Issue 3, 2015, Pages 325-331

  Brandt, Benny ^b   Mazaki Tovi, Shali ^b   Hemi, Rina ^a   Yinon, Yoav ^a,b   Schiff, Eyal ^a,b   Mashiach, Roy ^a,b   Kanety, Hannah ^a,b   Sivan, Eyal ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Adipocytokine; Adipose tissue; Cord blood; Omentin; Placenta; Pregnancy

Indexed keywords

ADIPOCYTOKINE; GLUCOSE; INSULIN; OMENTIN; UNCLASSIFIED DRUG; CYTOKINE; GLUCOSE BLOOD LEVEL; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; DELIVERY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LONGITUDINAL STUDY; MATERNAL SERUM; NEWBORN; NORMAL HUMAN; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUERPERIUM; THIRD TRIMESTER PREGNANCY; UMBILICAL CORD BLOOD; BLOOD; METABOLISM; SECRETION (PROCESS);

ADULT; BLOOD GLUCOSE; CYTOKINES; FEMALE; GPI-LINKED PROTEINS; HUMANS; INFANT, NEWBORN; INSULIN; INSULIN RESISTANCE; LECTINS; LONGITUDINAL STUDIES; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY TRIMESTER, THIRD;

EID: 84934764087     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/jpm-2014-0215     Document Type: Article

References (60)

1. Barker G, Lim R, Georgiou H.M., Lappas M. Omentin-1 is decreased in maternal plasma, placenta and adipose tissue of women with pre-existing obesity. PLoS One. 2012; 7:e42943.
2. Beck P. Progestin enhancement of the plasma insulin response to glucose in Rhesus monkeys. Diabetes. 1969; 18:146-52.
3. Briana DD, Boutsikou M, Baka S., Gourgiotis D, Marmarinos A, Liosi S., et al. Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies. Metabolism. 2011; 60:486-90.
4. Briana DD, Malamitsi-Puchner A. Adipocytokines in normal and complicated pregnancies. Reprod Sci. 2009; 16:921-37.
5. Cai RC, Wei L, Di J.Z., Yu HY, Bao YQ, Jia WP. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients]. Zhonghua Yi Xue Za Zhi. 2009; 89:381-4. [In Chinese].
6. Catalano PM, Hoegh M, Minium J., Huston-Presley L, Bernard S, Kalhan S., et al. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia. 2006; 49:1677-85.
7. Chan TF, Tsai YC, Wu C.H., Lee CH, Wang SH, Su JH. The positive correlation between cord serum retinol-binding protein 4 concentrations and fetal growth. Gynecol Obstet Invest. 2011; 72:98-102.
8. Chen D, Dong M, Fang Q., He J, Wang Z, Yang X. Alterations of serum resistin in normal pregnancy and pre-eclampsia. Clin Sci (Lond). 2005; 108:81-4.
9. Cho GJ, Yoo SW, Hong S.C., Oh MJ, Kim T, Kim HJ, et al Correlations between umbilical and maternal serum resistin levels and neonatal birth weight. Acta Obstet Gynecol Scand. 2006; 85:1051-6.
10. Corbetta S, Bulfamante G, Cortelazzi D., Barresi V, Cetin I, Mantovani G., et al. Adiponectin expression in human fetal tissues during mid- and late gestation. J Clin Endocrinol Metab. 2005; 90:2397-402.
11. Cortelazzi D, Corbetta S, Ronzoni S., Pelle F, Marconi A, Cozzi V., et al. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol (Oxf). 2007; 66:447-53.
12. D'Anna R., Baviera G, Corrado F., Giordano D, Di Benedetto A, Jasonni VM. Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders. Obstet Gynecol. 2005; 106:340-4.
13. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006; 444:881-7.
14. Fasshauer M, Bluher M, Stumvoll M., Tonessen P, Faber R, Stepan H. Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function. Clin Endocrinol (Oxf). 2007; 66:434-9.
15. Fasshauer M, Waldeyer T, Seeger J., Schrey S, Ebert T, Kratzsch J., et al. Serum levels of the adipokine visfatin are increased in pre-eclampsia. Clin Endocrinol (Oxf). 2008; 69:69-73.
16. Haider DG, Handisurya A, Storka A., Vojtassakova E, Luger A, Pacini G., et al. Visfatin response to glucose is reduced in women with gestational diabetes mellitus. Diabetes Care. 2007; 30:1889-91.
17. Haugen F, Ranheim T, Harsem N.K., Lips E., Staff AC, Drevon CA. Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression. Am J Physiol Endocrinol Metab. 2006; 290:E326-33.
18. Kazama K, Usui T, Okada M., Hara Y, Yamawaki H. Omentin plays an anti-inflammatory role through inhibition of TNF-alpha-induced superoxide production in vascular smooth muscle cells. Eur J Pharmacol. 2012; 686:116-23.
19. Krzyzanowska K, Zemany L, Krugluger W., Schernthaner GH, Mittermayer F, Schnack C, et al Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes. Diabetologia. 2008; 51:1115-22.
20. Kuzmicki M, Telejko B, Szamatowicz J., Zonenberg A, Nikolajuk A, Kretowski A., et al. High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Gynecol Endocrinol. 2009; 25:258-63.
21. Laudes M, Oberhauser F, Bilkovski R., Schubert M, Udelhoven M, Wassmer G., et al. Human fetal adiponectin and retinol-binding protein (RBP)-4 levels in relation to birth weight and maternal obesity. Exp Clin Endocrinol Diabetes. 2009; 117:146-9.
22. Lewandowski K, Nadel I, Lewinski A., Bienkiewicz M, Tan B, Randeva H.S., et al. Positive correlation between serum omentin and thrombospondin-1 in gestational diabetes despite lack of correlation with insulin resistance indices. Ginekol Pol. 2010; 81:907-12.
23. Lopez-Bermejo A., Fernandez-Real JM, Garrido E., Rovira R, Brichs R, Genaro P., et al. Maternal soluble tumour necrosis factor receptor type 2 (sTNFR2) and adiponectin are both related to blood pressure during gestation and infant's birthweight. Clin Endocrinol (Oxf). 2004; 61:544-52.
24. Malamitsi-Puchner A., Briana DD, Gourgiotis D, Boutsikou M., Baka S, Hassiakos D. Blood visfatin concentrations in normal full-term pregnancies. Acta Paediatr. 2007; 96:526-9.
25. Malamitsi-Puchner A., Gourgiotis D, Boutsikou M., Baka S, Hassiakos D, Briana DD Circulating apelin concentrations in mother/infant pairs at term. Acta Paediatr. 2007; 96:1751-4.
26. Maruyama S, Shibata R, Kikuchi R., Izumiya Y, Rokutanda T, Araki S., et al. Fat-derived factor omentin stimulates endothelial cell function and ischemia-induced revascularization via endothelial nitric oxide synthase-dependent mechanism. J Biol Chem. 2012; 287:408-17.
27. Matthews DR, Hosker JP, Rudenski A.S., Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28:412-9.
28. Mazaki-Tovi S., Kanety H, Pariente C., Hemi R, Efraty Y, Schiff E., et al. Determining the source of fetal adiponectin. J Reprod Med. 2007; 52:774-8.
29. Mazaki-Tovi S., Kanety H, Pariente C., Hemi R, Schiff E, Sivan E. Cord blood adiponectin in large-for-gestational age newborns. Am J Obstet Gynecol. 2005; 193:1238-42.
30. Mazaki-Tovi S., Kanety H, Pariente C., Hemi R, Wiser A, Schiff E., et al. Maternal serum adiponectin levels during human pregnancy. J Perinatol. 2007; 27:77-81.
31. Mazaki-Tovi S., Kanety H, Pariente C., Hemi R, Yissachar E, Schiff E., et al. Insulin sensitivity in late gestation and early postpartum period: the role of circulating maternal adipokines. Gynecol Endocrinol. 2011; 27:725-31.
32. Mazaki-Tovi S., Kanety H, Sivan E. Adiponectin and human pregnancy. Curr Diab Rep. 2005; 5:278-81.
33. Mazaki-Tovi S., Romero R, Kim S.K., Vaisbuch E., Kusanovic JP, Erez O, et al. Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA? J Matern Fetal Neonatal Med. 2010; 23:857-68.
34. Mazaki-Tovi S., Romero R, Kusanovic J.P., Erez O., Gotsch F, Mittal P, et al Visfatin/Pre-B cell colony-enhancing factor in amniotic fluid in normal pregnancy, spontaneous labor at term, preterm labor and prelabor rupture of membranes: an association with subclinical intrauterine infection in preterm parturition. J Perinat Med 2008; 36:485-96.
35. Mazaki-Tovi S., Romero R, Kusanovic J.P., Erez O., Vaisbuch E, Gotsch F, et al Adiponectin multimers in maternal plasma. J Matern Fetal Neonatal Med. 2008; 21:796-815.
36. Mazaki-Tovi S., Romero R, Kusanovic J.P., Vaisbuch E., Erez O, Than NG, et al Maternal visfatin concentration in normal pregnancy. J Perinat Med. 2009; 37:206-17.
37. Mazaki-Tovi S., Romero R, Kusanovic J.P., Vaisbuch E., Erez O, Than NG, et al Visfatin in human pregnancy: maternal gestational diabetes vis-a-vis neonatal birthweight. J Perinat Med. 2009; 37:218-31.
38. Mazaki-Tovi S., Romero R, Vaisbuch E., Chaiworapongsa T, Erez O, Mittal P., et al. Low circulating maternal adiponectin in patients with pyelonephritis: adiponectin at the crossroads of pregnancy and infection. J Perinat Med. 2009; 38:9-17.
39. Mazaki-Tovi S., Romero R, Vaisbuch E., Erez O, Chaiwaropongsa T, Mittal P., et al. Maternal plasma visfatin in preterm labor. J Matern Fetal Neonatal Med. 2009; 22:693-704.
40. Mazaki-Tovi S., Romero R, Vaisbuch E., Erez O, Mittal P, Chaiwaropongsa T., et al. Dysregulation of maternal serum adiponectin in preterm labor. J Matern Fetal Neonatal Med. 2009; 22:887-904.
41. Mazaki-Tovi S., Romero R, Vaisbuch E., Erez O, Mittal P, Chaiwaropongsa T., et al. Maternal serum adiponectin multimers in patients with a small-for-gestational-age newborn. J Perinat Med. 2009; 37:623-35.
42. Mazaki-Tovi S., Romero R, Vaisbuch E., Erez O, Mittal P, Chaiwaropongsa T., et al. Maternal serum adiponectin multi mers in gestational diabetes. J Perinat Med. 2009; 37:637-50.
43. Mazaki-Tovi S., Romero R, Vaisbuch E., Kim SK, Kusanovic JP, Chaiworapongsa T, et al Evidence for differential regulation of the adipokine visfatin in the maternal and fetal compartments in normal spontaneous labor at term. J Perinat Med. 2010; 38:281-8.
44. Mazaki-Tovi S., Romero R, Vaisbuch E., Kusanovic JP, Chaiworapongsa T, Kim SK, et al Retinol-binding protein 4: a novel adipokine implicated in the genesis of LGA in the absence of gestational diabetes mellitus. J Perinat Med. 2010; 38:147-55.
45. Mazaki-Tovi S., Romero R, Vaisbuch E., Kusanovic JP, Erez O, Gotsch F, et al Maternal serum adiponectin multimers in preeclampsia. J Perinat Med. 2009; 37:349-63.
46. Mazaki-Tovi S., Romero R, Vaisbuch E., Kusanovic JP, Erez O, Mittal P, et al Adiponectin in amniotic fluid in normal pregnancy, spontaneous labor at term, and preterm labor: A novel association with subclinical intrauterine infection/inflammation. J Matern Fetal Neonatal Med. 2009; 23:120-30.
47. Mazaki-Tovi S., Vaisbuch E, Romero R., Kusanovic JP, Chaiworapongsa T, Kim SK, et al Maternal and neonatal circulating visfatin concentrations in patients with pre-eclampsia and a small-for-gestational age neonate. J Matern Fetal Neonatal Med. 2010; 23:1119-28.
48. McLachlan KA, O'Neal D, Jenkins A, Alford FP Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes Metab Res. Rev. 2006; 22:131-8.
49. Phelps RL, Metzger BE, Freinkel N. Carbohydrate metabolism in pregnancy. XVII. Diurnal profiles of plasma glucose, insulin, free fatty acids, triglycerides, cholesterol, and individual amino acids in late normal pregnancy. Am J Obstet Gynecol. 1981; 140:730-6.
50. Ramsay JE, Jamieson N, Greer I.A., Sattar N. Paradoxical elevation in adiponectin concentrations in women with preeclampsia. Hypertension. 2003; 42:891-4.
51. Ranheim T, Haugen F, Staff A.C., Braekke K., Harsem NK, Drevon CA. Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet Gynecol Scand. 2004; 83:341-7.
52. Ryan EA. Hormones and insulin resistance during pregnancy. Lancet. 2003; 362:1777-8.
53. Ryan EA, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab. 1988; 67:341-7.
54. Samaras K, Botelho NK, Chisholm D.J., Lord RV. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes. Obesity (Silver Spring). 2010; 18:884-9.
55. Sivan E, Mazaki-Tovi S, Pariente C., Efraty Y, Schiff E, Hemi R., et al. Adiponectin in human cord blood: relation to fetal birth weight and gender. J Clin Endocrinol Metab. 2003; 88:5656-60.
56. Tchernof A, Belanger C, Morisset A.S., Richard C., Mailloux J, Laberge P, et al Regional differences in adipose tissue metabolism in women: minor effect of obesity and body fat distribution. Diabetes. 2006; 55:1353-60.
57. Van Harmelen V., Reynisdottir S, Eriksson P., Thörne A, Hoffstedt J., Lönnqvist F, et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes. 1998; 47:913-7.
58. Worda C, Leipold H, Gruber C., Kautzky-Willer A, Knofler M, Bancher-Todesca D. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. Am J Obstet Gynecol. 2004; 191:2120-4.
59. Wronska A, Kmiec Z. Structural and biochemical characteristics of various white adipose tissue depots. Acta Physiol (Oxf). 2012; 205:194-208.
60. Yang RZ, Lee MJ, Hu H, Pray J., Wu HB, Hansen BC, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab. 2006; 290:E1253-61.